ORBIMED ADVISORS LLC Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$10.5T
Holdings
138
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (138 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ARGXARGENX SE | 500,000 | $11.3B | 0.11% | |
| 102 | AUPHAURINIA PHARMACEUTICALS INC | 1,797,400 | $11.3B | 0.11% | |
| 103 | PRQRPROQR THRAPEUTICS N V | 2,295,346 | $11.1B | 0.11% | |
| 104 | HRTXHERON THERAPEUTICS INC | 650,000 | $10.5B | 0.10% | |
| 105 | VRNAVERONA PHARMA PLC | 666,666 | $10.2B | 0.10% | |
| 106 | —NEWLINK GENETICS CORP | 881,274 | $9.0B | 0.09% | Call |
| 107 | FLBFLUIDIGM CORP DEL | 1,746,100 | $8.8B | 0.08% | |
| 108 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 394,270 | $7.5B | 0.07% | |
| 109 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $7.4B | 0.07% | |
| 110 | ALKSALKERMES PLC | 145,000 | $7.4B | 0.07% | |
| 111 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,469,524 | $7.2B | 0.07% | |
| 112 | TEVATEVA PHARMACEUTICAL INDS LTD | 405,500 | $7.1B | 0.07% | |
| 113 | SRPTSAREPTA THERAPEUTICS INC | 150,000 | $6.8B | 0.07% | Call |
| 114 | CRSPCRISPR THERAPEUTICS AG | 372,191 | $6.7B | 0.06% | |
| 115 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $6.1B | 0.06% | |
| 116 | HALOHALOZYME THERAPEUTICS INC | 350,000 | $6.1B | 0.06% | |
| 117 | —SIERRA ONCOLOGY INC | 3,703,704 | $5.7B | 0.05% | |
| 118 | ZBHZIMMER BIOMET HLDGS INC | 49,000 | $5.7B | 0.05% | |
| 119 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $5.5B | 0.05% | |
| 120 | SNDXSYNDAX PHARMACEUTICALS INC | 437,000 | $5.1B | 0.05% | |
| 121 | MCRB1EURSERES THERAPEUTICS INC | 294,458 | $4.7B | 0.05% | Call |
| 122 | GLYCEURGLYCOMIMETICS INC | 337,588 | $4.7B | 0.05% | |
| 123 | —MARINUS PHARMACEUTICALS INC | 567,600 | $3.3B | 0.03% | |
| 124 | INFIQINFINITY PHARMACEUTICALS INC | 2,207,245 | $2.9B | 0.03% | |
| 125 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $2.8B | 0.03% | |
| 126 | OTICEUROTONOMY INC | 644,074 | $2.1B | 0.02% | |
| 127 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $2.0B | 0.02% | |
| 128 | XENEXENON PHARMACEUTICALS INC | 634,812 | $1.9B | 0.02% | |
| 129 | —BIOLINERX LTD | 1,038,600 | $1.2B | 0.01% | |
| 130 | —AFFIMED N V | 326,650 | $735.0M | 0.01% | |
| 131 | —NOVELION THERAPEUTICS INC | 100,000 | $703.0M | 0.01% | |
| 132 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $602.0M | 0.01% | |
| 133 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $558.0M | 0.01% | |
| 134 | —XTANT MED HLDGS INC | 475,439 | $343.0M | 0.00% | |
| 135 | —ALIMERA SCIENCES INC | 250,000 | $338.0M | 0.00% | |
| 136 | —ROKA BIOSCIENCE INC | 201,617 | $147.0M | 0.00% | |
| 137 | —MEDIGUS LTD | 60,000 | $134.0M | 0.00% | |
| 138 | —VERSARTIS INC | 50,000 | $123.0M | 0.00% | Call |
PreviousPage 2 of 2